Gut Microbiome Interactions in Primary Sclerosing Cholangitis
| dc.contributor.advisor | Altorjay, István | |
| dc.contributor.advisordept | Általános Orvostudományi Kar::Belgyógyászati Intézet::Gastroenterológiai Tanszék | |
| dc.contributor.author | Ndukwe, Amarachi | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | |
| dc.contributor.opponent | Palatka, Károly | |
| dc.contributor.opponent | Kovács, Renátó | |
| dc.contributor.opponentdept | Általános Orvostudományi Kar::Belgyógyászati Intézet::Gastroenterológiai Tanszék | |
| dc.contributor.opponentdept | Általános Orvostudományi Kar::Orvosi Mikrobiológiai Intézet | |
| dc.date.accessioned | 2026-11-16T10:55:39Z | |
| dc.date.created | 2026 | |
| dc.description.abstract | Primary sclerosing cholangitis (PSC) is a rare, progressive immune-mediated cholangiopathy with substantial risks of liver failure, colorectal neoplasia, and cholangiocarcinoma. This thesis examines evidence that genetic susceptibility, intestinal dysbiosis, barrier dysfunction, immune activation, and altered bile-acid signalling interact within a self-reinforcing gut-liver axis. PSC-associated dysbiosis is characterized by reduced microbial diversity, enrichment of pathobionts, depletion of SCFA-producing bacteria, and altered microbial metabolic functions. Impaired intestinal-barrier integrity may permit microbial products to reach the liver and activate inflammatory pathways in immune cells and cholangiocytes, promoting periductal fibrosis. Microbiome- and bile-acid-directed treatments have shown preliminary benefits, but none has demonstrated sustained improvement in transplant-free survival or disease prevention. Future progress requires longitudinal multiomic studies and rigorous clinical trials using appropriately stratified patients and clinically meaningful endpoints. | |
| dc.description.course | általános orvos | |
| dc.description.courselang | angol | |
| dc.description.degree | egységes, osztatlan | |
| dc.format.extent | 78 | |
| dc.identifier.uri | https://hdl.handle.net/2437/417308 | |
| dc.language.iso | en | |
| dc.rights.info | Hozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében. | |
| dc.subject | primary sclerosing cholangitis | |
| dc.subject | PSC | |
| dc.subject | gut microbiome | |
| dc.subject | gut-liver axis | |
| dc.subject | intestinal dysbiosis | |
| dc.subject | bile acid metabolism | |
| dc.subject | inflammatory bowel disease | |
| dc.subject | IBD | |
| dc.subject.dspace | Medicine::Internal Medicine | |
| dc.subject.dspace | Medicine::Medical microbiology | |
| dc.title | Gut Microbiome Interactions in Primary Sclerosing Cholangitis |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Betöltés ...
- Név:
- [Amarachi Ndukwe] Gut Microbiome Interactions in Primary Sclerosing Cholangitis.pdf
- Méret:
- 32,2 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- [Amarachi Ndukwe] Gut Microbiome Interactions in Primary Sclerosing Cholangitis